drugset / Trial / NCT03415906

Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure

NCT03415906 ↗

RandomizedCrossoverDouble-blindBasic science

Summary

The autonomic nervous system plays an important role in controlling the circulation. Increased sympathetic activity has detrimental effects in patients with heart failure. The purpose of this study is to test the hypothesis that combined angiotensin receptor + neprilysin inhibition results in lower sympathetic activity than angiotensin receptor inhibition alone.

Timeline

Start
2017-12-14
Primary completion
2018-09-06
Completion
2018-09-06

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulties in recruiting patients”

Drugs

EvaluationDrugModalityDoseRoute
Subject Sacubitril/Valsartan Unknown — —
Comparator Valsartan Unknown — —

Indications